Austria vs Sweden: The number of people with susceptibility test result for rifampicin
Austria
165
in 2021
Sweden
173
in 2021
Austria rank
98th
Sweden rank
97th
The number of people with susceptibility test result for rifampicin over time
- Austria
- Sweden
How they compare
Sweden currently reports 173 against 165 in Austria, a difference of 8.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Austria ahead.
Austria ranks 98th and Sweden ranks 97th of 155 countries.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Austria | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 220.67 | 255 | 34.33 | Sweden |
| 2020s | 169 | 171 | 2 | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Austria or Sweden?
- Sweden, at 173 against 165 in Austria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Austria and Sweden?
- 8, with Sweden ahead.
- How many years of comparable data are there for Austria and Sweden?
- 5 years are reported by both, from 2017 to 2021.
- How do Austria and Sweden rank globally for the number of people with susceptibility test result for rifampicin?
- Austria ranks 98th and Sweden ranks 97th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.